Orange Book product · Generic (ANDA)
BETAMETHASONE VALERATE
BETAMETHASONE VALERATE
At a glance
Aug 22, 2024
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Aug 22, 2024
1 yr 10 mo ago
Today
Pharmaceutical detail
Active ingredient
BETAMETHASONE VALERATE
Strength
0.12%
Dosage form
AEROSOL, FOAM
Route
TOPICAL
TE code
AB
Application
ANDA 215832
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of BETAMETHASONE VALERATE
- 1999LUXIQBrand (NDA)
NDA 020934 · PHARMOBEDIENT
- 1983BETAMETHASONE VALERATEBrand (NDA)
NDA 018861 · FOUGERA PHARMS INC
- 1983BETAMETHASONE VALERATEBrand (NDA)
NDA 018860 · PHARMADERM
- 1983BETATREXBrand (NDA)
NDA 018862 · SAVAGE LABS
- 1983BETAMETHASONE VALERATEBrand (NDA)
NDA 018866 · FOUGERA PHARMS INC
- 1983BETAMETHASONE VALERATEBrand (NDA)
NDA 018870 · PHARMADERM
- 1983BETATREXBrand (NDA)
NDA 018867 · SAVAGE LABS
- 1983BETAMETHASONE VALERATEBrand (NDA)
NDA 018865 · FOUGERA PHARMS INC
- 1983BETAMETHASONE VALERATEBrand (NDA)
NDA 018864 · PHARMADERM
- 1983BETATREXBrand (NDA)
NDA 018863 · SAVAGE LABS
- 1983BETADERMBrand (NDA)
NDA 018839 · ROACO
- 1983BETA-VALBrand (NDA)
NDA 018642 · COSETTE PHARMS NC
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
